Anti-IgE therapy results in decreased myeloid dendritic cells in asthmatic airways.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 20304471.
- Also identified by DOI 10.1016/j.jaci.2010.01.020 and PMC identifier 2866812.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Anti-IgE treatment of intermittent to mild-persistent asthma in a cohort of seven volunteers resulted in improved allergen-induced airway hyperreactivity and a significant reduction in the number of airway myeloid dendritic cells.
Medical subject headings
- Antibodies, Anti-Idiotypic
- Antibodies, Monoclonal
- Asthma
- Bronchi
- Dendritic Cells
- Myeloid Cells